Back to Search Start Over

Iris volume change with physiologic mydriasis to identify development of angle closure: the Zhongshan Angle Closure Prevention Trial

Authors :
Liao, Chimei
Quigley, Harry
Jiang, Yuzhen
Huang, Shengsong
Huang, Wenyong
Friedman, David
Foster, Paul J
He, Mingguang
Source :
British Journal of Ophthalmology; 2024, Vol. 108 Issue: 3 p366-371, 6p
Publication Year :
2024

Abstract

AimsTo assess dynamic change of iris area (Iarea) and volume (VOL) with physiologic pupil dilation for progression of primary angle closure suspects.MethodsParticipants underwent baseline examinations including gonioscopy and anterior segment OCT (AS-OCT) as part of the Zhongshan Angle Closure Prevention Trial. The AS-OCT images were obtained both in the dark and light. Progression was defined as development of primary angle closure or an acute angle closure attack. Static ocular biometrics and dynamic changes were compared between progressors and non-progressors and multivariable logistic regression was developed to assess risk factors for progression.ResultsA mean 16.8% decrease in Iarea and a mean 6.26% decrease in VOL occurred with pupil dilation, while 22.96% non-progressors and 40% progressors presented VOL increases with pupil dilation. Iarea in light and dark and VOL in light were significantly smaller in progressors. In a multivariable logistic model, older age (p=0.008), narrower horizontal angle opening distance (AOD) 250 µm from the scleral spur (AOD250, p=0.001), flatter iris curvature (IC, p=0.006) and lower loss of iris volume (ΔVOL, p=0.04) were significantly associated with progression. With receiver operating characteristic analysis, the area under the curve for ΔVOL alone was 0.621, while that for the combined index (age, AOD250, IC and ΔVOL) was 0.824. Eyes with elevated intraocular pressure had less VOL loss compared with progressors developing peripheral anterior synechiae alone (p=0.055 for ΔVOL adjusted for pupil enlargement).ConclusionA smaller change in ΔVOL is an additive risk factor to identify eyes more likely to develop angle closure disease.Trial registration numberISRCTN45213099.

Details

Language :
English
ISSN :
00071161 and 14682079
Volume :
108
Issue :
3
Database :
Supplemental Index
Journal :
British Journal of Ophthalmology
Publication Type :
Periodical
Accession number :
ejs65541979
Full Text :
https://doi.org/10.1136/bjo-2022-322981